Atara Biotherapeutics IPO delayed by new test results

Atara Biotherapeutics postponed its expected Thursday IPO after it got new information about one of its drugs, according to a report from Thomson Reuters...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.